Detalles de la búsqueda
1.
Similar efficacy outcomes with peripheral blood stem cell versus bone marrow for autologous stem cell transplantation in acute myeloid leukemia: Long-term follow-up of the EORTC-GIMEMA randomized AML-10 trial.
Am J Hematol
; 99(3): 486-489, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38174977
2.
Impact of the type of anthracycline and of stem cell transplantation in younger patients with acute myeloid leukaemia: Long-term follow up of a phase III study.
Am J Hematol
; 95(7): 749-758, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32233095
3.
A prospective observational study to assess clinical decision-making, prognosis, quality of life and satisfaction with care in patients with relapsed/refractory multiple myeloma: the CLARITY study protocol.
Health Qual Life Outcomes
; 16(1): 127, 2018 Jun 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-29914509
4.
Physicians' attitude towards selection of second line therapy with nilotinib and dasatinib in chronic myeloid leukemia patients.
Health Qual Life Outcomes
; 15(1): 204, 2017 Oct 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-29047379
5.
Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients.
Haematologica
; 105(1): e13-e16, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31097634
6.
Enhanced and aberrant T cell trafficking following total body irradiation: a gateway to graft-versus-host disease?
Br J Haematol
; 162(6): 808-18, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23855835
7.
Chimeric Antigen Receptor T-cell Therapy in Hematologic Malignancies and Patient-reported Outcomes: A Scoping Review.
Hemasphere
; 6(12): e802, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36504547
8.
Patient-reported outcomes for the myelodysplastic syndromes: a new MDS-specific measure of quality of life.
Blood
; 123(3): 451-2, 2014 Jan 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-24434998
9.
Health-related quality of life in patients with acute promyelocytic leukemia: a systematic literature review.
Expert Rev Hematol
; 14(7): 645-654, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34125642
10.
Cytogenetic and molecular responses in chronic phase chronic myeloid leukaemia patients receiving low dose of imatinib for intolerance to standard dose.
Hematol Oncol
; 28(2): 89-92, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19728398
11.
Quality of patient-reported outcome reporting in randomised controlled trials of haematological malignancies according to international quality standards: a systematic review.
Lancet Haematol
; 7(12): e892-e901, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33242446
12.
Comorbidities and FLT3-ITD abnormalities as independent prognostic indicators of survival in elderly acute myeloid leukaemia patients.
Hematol Oncol
; 27(3): 148-53, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19274612
13.
Ocular side effects in chronic myeloid leukemia patients treated with imatinib.
Leuk Res
; 32(7): 1022-5, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18061664
14.
Isolated thrombocytosis as first sign of chronic myeloid leukemia with e6a2 BCR/ABL fusion transcript, JAK2 negativity and complete response to imatinib.
Leuk Res
; 32(1): 177-80, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17688946
15.
Rituximab associated to imatinib for coexisting therapy-related chronic myeloid leukaemia and relapsed non-Hodgkin lymphoma.
Leuk Res
; 32(2): 353-5, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-17825907
16.
How should we assess patient-reported outcomes in the onco-hematology clinic?
Curr Opin Support Palliat Care
; 12(4): 522-529, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30239387
17.
Very short-term lenalidomide treatment associated with durable resolution of anemia in a patient with myelodysplastic syndrome with chromosome 5q deletion.
Ann Hematol
; 91(2): 309-10, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21625998
18.
The value of quality of life assessment in chronic myeloid leukemia patients receiving tyrosine kinase inhibitors.
Hematology Am Soc Hematol Educ Program
; 2016(1): 170-179, 2016 Dec 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27913477
19.
Reduction of imatinib dose and persistence of complete molecular response after p210 multipeptide vaccine in chronic myeloid leukaemia treated with dose escalation for acquired resistance.
Br J Haematol
; 150(2): 240-2, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20346015
20.
Early hemorrhagic death before starting therapy in acute promyelocytic leukemia: association with high WBC count, late diagnosis and delayed treatment initiation.
Haematologica
; 95(5): 853-4, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20015875